
India approves first dengue vaccine for 4-60 age group
The story in brief
The Central Drugs Standard Control Organisation (CDSCO) approved Takeda Pharmaceutical's QDENGA, making it the first dengue vaccine to be approved in India for individuals aged 4 to 60. QDENGA, a tetravalent live-attenuated vaccine, is recommended by the WHO and already used in Brazil, Argentina, Colombia, and Indonesia. India accounts for nearly one-third of the global dengue burden, with reported cases rising 11-fold over two decades.